Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics - Related Studies

Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics

This study is currently recruiting participants.

Study NCT00607230. Last updated on July 7, 2008. Information provided by Massachusetts General Hospital

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Type 1 Diabetes Mellitus

2	Additional conditions recognized in this trial
		Diabetes Mellitus
		Diabetes Mellitus, Type 1

3	More general conditions related to this trial
		Autoimmune Diseases
		Endocrine System Diseases
		Glucose Metabolism Disorders
		Immune System Diseases
		Metabolic Diseases

4	Interventions listed in this trial
		BCG
		Saline

5	Sponsors listed in this trial
		Massachusetts General Hospital
		Iacocca Foundation